morphine sulfate 150 mg/30 mL in 0.9% Sodium Chloride Injection, (5 mg/mL), Rx Only, 30 mL Single...

FDA Recall #D-0202-2021 — Class II — December 17, 2020

Recall #D-0202-2021 Date: December 17, 2020 Classification: Class II Status: Terminated

Product Description

morphine sulfate 150 mg/30 mL in 0.9% Sodium Chloride Injection, (5 mg/mL), Rx Only, 30 mL Single Dose Syringe, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004010316

Reason for Recall

Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

Recalling Firm

SCA Pharmaceuticals — Windsor, CT

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

50 syringes

Distribution

Product was distributed to hospitals nationwide.

Code Information

Lot # 1220023221, BUD 1/31/2021 & 1220023584, BUD 2/9/2021.

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated